This should be combined with other approaches for sustained weight management and metabolic health
Common incretin-related effects discussed in the broader GLP-1 and metabolic drug class may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation, or abdominal discomfort, but trial observations do not establish safe personal use of a research peptide
The single-dose segment held the largest share, owing primarily to its ease of administration and convenience for patients
But theres no research showing what happens when berberine is applied in patch form, he adds
doi: 10.1002/oby.22726 39 FinanBClemmensenCMllerTD
These are encouraging surrogate markers, but they are not the same as proven cardiovascular event reduction